Epirium Bio inks $85 mln Series A

San Diego-based Epirium Bio Inc, a clinical-stage biopharmaceutical company, has raised $85 million in Series A financing.

San Diego-based Epirium Bio Inc, a clinical-stage biopharmaceutical company, has raised $85 million in Series A financing. The investors were Longitude Capital, ARCH Venture Partners, Bluebird Ventures, Adams Street Partners, Vertex Ventures HC and The Longevity Fund.

Source: Press Release